< Back to Search

Neurology® Podcast - December 15 2009 Issue

A phase 2 multiple ascending dose trail of bapineuzumab in mild to moderate Alzheimer disease

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interview Dr. Stephen Salloway about his paper on using bapineuzumab in mild to moderate Alzheimer disease. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about the Heidenhain variant of Creutzfeldt Jakob disease. The podcast concludes where Dr. Beau Bruce interviews Dr. Brian Weinshenker for the Lesson of the Week (disease of the month) on triptans. The participants had nothing to disclose except Drs Read More

Download this Episode

Episode Segments


00:31 01:08

Play Segment

Interview:using bapineuzumab in mild to moderate Alzheimer disease

ePearl1:Heidenhain variant of Creutzfeldt Jakob disease

11:33 12:45

Play Segment

MeSH Terms


12:46 24:35

Play Segment

MeSH Terms

ePearl2:Creutzfeldt Jakob disease

24:36 25:34

Play Segment

MeSH Terms


25:35 27:54

Play Segment



Email pbaskin@neurology.org